Clinical Trial Update: A Study of MGC028 in Participants With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Clinical trial update for MGC028 in participants with advanced solid tumors. This Phase 1 study is currently recruiting to evaluate safety and dosing across mul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma
• Colorectal Cancer
• Non-small Cell Lung Cancer
• Pancreatic Cancer

Drugs mentioned

• MGC028

Snippet

Sponsor: MacroGenics | Conditions: Advanced Solid Tumors, NSCLC Adenocarcinoma | Phase 1 | Status: RECRUITING